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Background: Mucopolysaccharidosis relates to a group of seven prevalent types of disorders that are categorized
on the basis of specific enzyme deficiency or the major symptoms, or both. A typical clinical presentation includes
such symptoms and characteristics as short stature, facial dysmorphism, skeletal deformities, pulmonary dysfunction,
joint stiffness and contractures, myocardial hypertrophy, neurological symptoms, and mental retardation.
Case presentation: The purpose of this study was to perform a detailed anthropometric assessment in four cases
of children with mucopolysaccharidosis (MPS) I and II types aged from 4 to 13 years from the Podkarpacie Province
(south-eastern Poland). Anthropometric assessment included several parameters and indices related to body
structure. All examined patients are characterized by severely disordered physical growth in comparison with the
Polish norms presented in the reference charts.
Conclusions: Examined children with MPS are characterized by especially low values relating to longitudinal and
transversal parameters of body build. Anthropometric data could be used in early diagnosis of MPS and assessment
of results of its treatment.
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The term mucopolysaccharidosis (MPS) relates to a
group of autosomal recessive metabolic disorders caused
by the absence or dysfunction of the lysosomal enzymes
involved in the degradation of glycosaminoglycals (GAGs).
The MPS group comprises the seven prevalent types of
disorder that are categorized on the basis of specific en-
zyme deficiency or the major clinical symptoms, or both
[1]. A typical clinical presentation includes such symptoms
and characteristics as short stature, facial dysmorphism,
skeletal deformities, pulmonary dysfunction, joint stiffness
and contractures, myocardial hypertrophy, neurological
symptoms, and mental retardation. In most cases patients
are symptomatic at the age of 2–4 years. Manifestation of
the disease may be confused with other diseases such as in-
flammatory arthitides [2]. It should be mentioned that de-
lays in diagnosis of MPS happen quite frequently and some
children will suffer for some time with an unrecognized
disorder. This kind of diseases are chronic and progressive
even when they are treated or not. Some types of MPS areCorrespondence: mieczrad@univ.rzeszow.pl
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reproduction in any medium, provided the ornow treatable by means of enzyme replacement therapy
and hematopoietic stem cell transplantation [3]. An im-
portant element of an exact assessment of the effects of
treatment is the evaluation of the physical growth pattern
in an individual patient. This kind of evaluation is based on
anthropometric data.
The main study objective was to present and analyze
selected anthropometric parameters and bodily propor-
tions in four children with MPS I and II in order to
highlight the distinctive manifestation of clinical symp-
toms of MPS in the dimension of physical development
of the affected children. Results of the study may be used
in the evaluation of the physical growth pattern of patients
with MPS, its deviation in comparison with the reference
charts and assessment of the effects of treatment.
Case presentation
The study population consisted of 4 cases of children (3
males with MPS II) and 1 female (with MPS I) aged
from 4 to 13 years. They represented the population of
children with MPS from the Podkarpacie Province
(south-eastern Poland) diagnosed at the time of examin-
ation (i.e. in 2010). The examination took place at thehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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2 in Rzeszow. The author was invited to perform an-
thropometric studies of the 4 children diagnosed with
MPS who participated in a special pharmacological
treatment project. Three boys with MPS II were treated
with Elaprase, and in the case of one girl with MPS I
(Scheie syndrome) Aldurazyme was applied. All the
children came from a rural social environment (Table 1).
The anthropometric measurements were taking during
an initial stage of the treatment programme. The follow-
ing tools were used: anthropometric tape, physician
scale, Martin anthropometer, and set of callipers (includ-
ing skinfold calliper). All of them were used according
to the standard anthropometric technique.
The examinations were based on the method of meas-
urement and analysis of anthropometric parameters de-
fined by Martin and Sailer [4]. Methodological principles
recommended by the International Society for Advance-
ment of Kinanthropometry were also followed [5]. The
following parameters were used to evaluate longitudinal
dimensionality: body mass, body height [B-v], trunk length
[sst-sy], head and neck height [v-sst], lower extremity
length [B-sy], and upper extremity length [a-adIII]. The
following parameters were used to evaluate transversal
dimensionality: shoulder breadth [a-a] and hip breadth
[ic-ic]. The cephalometric parameters used in the study
were: head length [g-op], head breadth [eu-eu], face
breadth [zy-zy], face height [n-gn], nose height [n-sn] and
nose breadth [al-al]. The circular dimensionalities were:
chest circumference, head circumference and arm circum-
ference. The chest circumference was measured through
xiphoidale (xi) point. Skinfold thickness was measured
with a constant-pressure skinfold caliper. The following
parameters of skinfold thickness were measured: triceps
skinfold, subscapular skinfold and suprailiac skinfold.
On the basis of anthropometric data the following in-
dexes of proportion were calculated: trunk length index,
head and neck for height index, shoulder-height index,
pelvic-height index, upper extremity length index, arm
length index, inter-extremity index, lower extremity length
index, shoulder breadth index, pelvic breadth index, hip-
to-shoulder index, global adiposity (sum of 3 skinfolds: tri-
ceps, subscapular, suprailiac), Body Mass Index (BMI),
Rohrer index, head-to-chest circumference index, Marty's
index of chest growth, arm muscles circumference index,
cross-section area of arm (mm2), cross-section area ofTable 1 Demographic information about children
Case no. 1 2 3 4
Age 11;1 13;7 12;1 4;4
Gender male male male female
Type of MPS II II II I
Social milieu rural rural rural ruralarm muscles (mm2), cross-section area of arm adipose tis-
sue (mm2), head breadth-to-length index, morphological
face index, head-to-nose index. Obtained results were ana-
lyzed with reference to the Polish norms elaborated by
Palczewska & Niedzwiecka [6].
All children with MPS I and II, independently of age
and gender, are characterized by severely disordered
growth. Both longitudinal and transversal parameters, as
body height [B-v), head and neck height [v-sst], trunk
length [sst-sy], lower extremity length [B-sy], shoulder
breadth [a-a], and hip breadth [ic-ic], correspond to values
much below the Polish norms presented in the reference
charts (in percentiles) [6-9].
The values of body height in each of the children ex-
amined are placed below 3rd centile, which means that
they are low-statured (Table 2). Analogically, values re-
lated to head and neck height [v-sst] and shoulder
breadth [a-a] in all cases are below the 3rd percentile on
the Polish reference charts. Hip breadths [ic-ic] in the
girl examined (case no. 4) and one boy (case no. 1) are
equal to the 3rd percentile, and in both remaining boys
(cases no. 2 and 3) this parameter falls below that range.
In all three boys the values of lower extremity length
[B-sy] and trunk length [sst-sy] are below the 3rd per-
centile, while in the girl, this parameter is placed in the
range between the 3-10th percentile.
The examined children are characterized by some typ-
ical body proportions. They are narrow-shouldered (in
relation to the values of shoulder-height index and hip-
to-shoulder index), short-legged (on the grounds of the
values of lower extremity length index), and are of very
weak body build (according to classification founded on
the Quetelet I index). The values of Marty's index point
to a significant growth of the chest: in one boy the value
of this parameter falls within the range of 90-97th per-
centile, and in the other children above the 97th percent-
ile. Analysis of cephalometric values indicates excessive
face breadth (hypereuryprosopus) as a characteristic trait
of the children. Values of global adiposity are also higher
than average (>75c).
Arm muscle circumference (AMC) in the children
runs into values much lower than average (<25c). For
example, the cross-sectional surface of arm adipose tis-
sue records markedly higher values (>75c).
A short trunk is a distinct characteristic of all the boys
with MPS II type, while the girl with MPS I has a relatively
long trunk. Interpretation of the remaining indexes of
proportion varies with each particular case. Nevertheless,
MPS is a factor which should be taken into consideration
during differentiation of the cause of a short stature.
Discussion
In the professional medical literature there is a lack of
publications containing detailed anthropometric data
Table 2 Anthropometric parameters of examined cases
Case no. 1 2 3 4
Body mass 27,6 kg (3-10c)* 33,2 kg (<3c) 27,5 kg (<3c) 16,7 kg (50–7 5c)
[B-v] 104,7 cm (<3c) 136,7 cm (<3c) 111 cm (<3c) 93,0 cm (<3c)
[B-sy] 57,3 cm (<3c) 70,7 cm (<3c) 58,8 cm (<3c) 45,3 cm (3-10c)
fsst-sy] 30 cm (<3c) 38,8 cm (<3c) 28,8 cm (<3c) 28,7 cm (3-10c)
[a-adIII] 47,2 cm 61.2 cm 41,5 cm 33,0 cm
[a-a] 20 cm (<3c) 25,8 cm (<3c) 24 cm (<3c) 19 cm (<3c)
[ic-ic] 20 cm (3c) 20,3 cm (<3c) 16,5 cm (<3c) 15,5 cm (3c)
[v-sst] 17,4 cm (<3c) 27,2 cm (<3c) 13,4 cm (<3c) 19 cm (<3c)
[g-op] 19 cm 18 cm 19 cm 17,5 cm
[eu-eu] 16 cm 16 cm 15 cm 14,5 cm
[n-gn] 10,5 cm 10,1 cm 10,5 cm 8,5 cm
[zy-zy] 13,5 cm 13,2 cm 14 cm 12 cm
[n-sn] 4 cm 4,2 cm 4 cm 3 cm
[al-al] 4 cm 3,3 cm 3,5 cm 3 cm
HC 55,5 cm (75-90c) 54 cm (25-50c) 58 cm (>97c) 52,5 cm (90-97c)
CC [xi] 64,5 cm (25-50c) 70 cm (25-50c) 65cm (10-25c) 56 cm (90-97c)
AC 22 cm (50-75c) 22,5 cm (25-50c) 20cm (10-25c) 18 cm (90-97c)
Subscapular
skinfold
30,3 mm (>97c) 11 mm (75-90c) 16 mm (90-97c) 13 mm (>97c)
Triceps skinfold 20,6 mm (>97c) 12 mm (75-90c) 22 mm (>97c) 19 mm (>97c)
Suprailiac
skinfold
30, lmm (>97c) 10 mm (50-75c) 30 mm (>97c)* 15 mm (>97c)
[sst-sv]×l00%
[B-v]
28,65 (25-50c) short trunked 28,38 (25- 50c) short trunked 25,94 (<3c) short trunked 30,86 (50-75c) long trunked
[a-a]×l00% [B-v] 19,1 narrow shouldered 18,87 narrow shouldered 21,62 narrow shouldered 20,43 narrow shouldered





44,76 short upper extremity 37,38 short upper extremity 35,48 short upper extremity
[a-r]×l00% [B-v] 21,96 long-armed 30,43 long-armed 17,11 short-armed 20,21 long armed
[a-daIII]×lOO%
[B-sy]
80,27 very long-legged 86,56 medium long-legged 70,57 very long-legged 72,84 very long-legged
[B-sy]×l00% [B-vl 54,72 (>97c) short-limbed 51,71 (10-25c) short-limbed 52,97 (50-75c) short-limbed 48,71 (75-90c) short-limbed
[a-a]×l00%
[sst-sy]
66,66 (<3c) narrow shoulders 66,49 (<3c) narrow shoulders 83,3 (<3c) broad shoulders 66,20 (<3c) narrow shoulders
[ic-ic]×l00%
[sst-sy]
66,66 52,31 57,29 54,00








BMI 25,17 kg/m2 (90-97c) 17,7 kg/m2 (25-50c) 22,31 kg/m2 (75-90c) 19,3 kg/m2 (>97c)
CC [xi]×l00%
[B-v]
61,60 (>97c) 51,20 (90-97c) 58,55 (>97c) 60,21 (>97c)
Global adiposity 81 mm(>97c) 33 mm (75-90c) 68 mm (>97c) 47 mm (>97c)
[v-sst]×l00% [B-v] 16,61 (<3c) 19,89 (>97c) 21,08 (>97c) 20,43 (<3c)
[eu-eu]×l00%
[g-op]
84,21 brachycephalus 88,88 hyperbrachy-cephalus 78,94 mesocephalus 82,5 brachycephalus
[n-gn]×l00%
[zy-zy]
74,07 hypereuryprosopus 75,75 hypereuryprosopus 75 hypereuryprosopus 70,83 hypereuryprosopus
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Table 2 Anthropometric parameters of examined cases (Continued)
[al-al]×l00%
[n-sn]
100,0 hyperchamaerrhinus 82,5 mesorrhinus 87,5 chamaerrhinus 100,0 hyperchamaerrhinus
MHC×l00%
CC[xi]
86,04 (75-90c) 77,14 (75-90c) 89,23 (>97c) 93,75 (10-25c)
Bodv mass (g)
[B-v] (cm)
263,6 very weak body build
(50-75c)
242,8 very weak body build
(3-10c)
247,7 very weak body build
(10-25c)




2,4 corpulent (>97c) 1,29 average (3-10c) 2,0 corpulent (>97c) 2,07 corpulent (>97c)
AC cm 15,53 (3-10c) 18,73 (10-25c) 13,09 (<3c) 12,03 (10-25o)
ACS (mm2) 3853 (50-75c) 4030 (25-50c) 3185 (10-25c) 2579 (90-97c)
CAM (mm2) 1920 (3-10c) 2793 (10-25c) 1364 (<3c) 1152 (3-10c)
CAAT (mm2) 1933 (75-90c) 1237 (50-75c) 1821 (75-90c) 1427 (>97c)
Endnotes: c – percentile.
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spectrum of diseases. Most of the studies concentrate on
individual cases and take into consideration only a
limited number of anthropometric characteristics. In
Poland, for example, several research studies have been
performed at the Children's Memorial Health Institute
in Warsaw. One of these studies was a long-term exam-
ination performed from 1989 to 2009 [7]. The study
group consisted of 28 boys with MPS II aged from 0,6 to
27 years. Analysis of results disclosed two phases of
physical growth: 1. progressive (during the first 3 years
of life, children with MPS II grew faster than the healthy
population), 2. pathological (since the end of the third
year of life all the measured parameters attained increas-
ingly lower values in comparison to the reference charts).
A negative growth trend for all features examined was
evidenced by significantly different values from the refer-
ence charts.
Similar studies were performed in other European coun-
tries, for example, in the Czech Republic and Slovakia [8].
The aim of the research cited was to describe the clinical
symptoms, typical course and to evaluate the results of
the treatment of 24 Czech and Slovak children with MPS
I. Most of the patients had macrocephaly and skeletal
changes, cardiomyopathy, hearing impairment, joint stiff-
ness, and carpal tunnel syndrome. The authors empha-
sized the role of the advanced diagnosis, including the
anthropometric parameters. Shah et al. [9] found in a 10-
year-old East-Asian boy with MPS such characteristics as
an acrocephalic head, short stature, short neck and small
stubby fingers with flexion of distal interphalangeal joint,
and mild mental retardation. Other authors emphasize
that ocular manifestations in MPS I and II may occur not
only in the form of corneal clouding, but also include
retinopathy, glaucoma, optic disc swelling, optic atrophy,
ocular motility and refractive error problems [10].
In practice, the results of anthropometric measure-
ments may be used in the diagnosis of some types ofMPS. For example, the phenotype of MPS IVA can be
classified into three subgroups according to the patient's
final height: severe (<120 cm), intermediate (between
120 and 140 cm) and mild (above 140 cm), respectively
[11]. The patients of the severe type are also character-
ized by features such as short stature, genu odontoid
dysplasia, valgum, protrusion of the chest, kyphoscoliosis,
hypermobility of joints and abnormal gait, and are mostly
below the 90th percentile on the Morquio A growth
charts. They often have the onset during infancy, and can-
not survive through the second or third decade of life.
The patients of the intermediate and mild types, generally
called 'attenuated' types, have relatively less skeletal in-
volvement and longer life span [12].
In the cases of our children the values of head
breadth-to-length index have revealed three types of
proportions: brachycephalic, hyperbrachycephalic and
mesocephalic. There was no child with an acrocephalic
or dolichocephalic head.
In the group of parameters relating to the process of
body growth, special attention must be given to short
stature, especially to low values characterizing the length
of trunk, head and neck height, lower extremity length,
and shoulder and hip breadth. Within the scope of in-
dexes describing the process of differentiation of body
proportions, the data obtained point to, in particular nar-
row shoulders (shoulder growth index), short-legs (relative
lower extremity length), and a high level of chest growth
(Marty's index).
Children with MPS are characterized by a higher de-
gree of adiposity, which is evidenced by relatively high
values of the parameters relating to global adiposity and
the cross-sectional area of arm adipose tissue. Children
with MPS also display a lower level of musculature de-
velopment in comparison to their normal peers, as
evidenced by the values referring to the cross-sectional
area of arm muscles. The boys examined are character-
ized by a short trunk, whereas the girl is long-statured.
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the different type of MPS.
On the basis of the morphological face index, it reveals
that all examined children are characterized by an exces-
sively broad face. In the group of the parameters describ-
ing the growth process, the following typical features were
observed: short stature, especially a short trunk, and lower
values referring to head and neck height, shoulder and hip
breadth. These findings correlate with the results of obser-
vations obtained by Shah and colleagues [9-13]. All our
children are more than 3-year-old and are characterized
not only by a short-stature but also by significantly lower
values relating to other aspects of the growth process.
Dysmorphic differences are also typical for children with
other kinds of diseases such as meningomyelocele [13].
Conclusions
1. On the basis of anthropometric measurement and
various indexes observed it can be concluded that
examined children with MPS are characterized by
especially low values relating to longitudinal and
transversal features of body build.
2. MPS is a disorder which should be taken into
consideration during diagnosis of causes of short
stature.
3. Some specificity in the formation of body
proportionality found in children with MPS could be
used in the early diagnosis of this rare disorder.
4. The data presented in Table 2 and final conclusions
should not be generalized to all children with MPS
but relate to these particular patients.
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